About
Ignacio Moraga is an immunologist and biotech founder focused on cytokine signaling and immune-cell fate decisions. He was previously a Principal Investigator at the University of Dundee, and Institut Pasteur's 2010 annual report notes that after defending his PhD thesis he joined Stanford University as a postdoctoral researcher. He is also a co-founder of Basel-based TECregen AG, a biotech developing therapies to enhance immune function.
Areas of interest
immunologycytokine signalingprotein engineeringimmune modulationregenerative medicinebiotechcancerinflammatory diseases